Skip to main content

Silvia Cabrera Diaz

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Silvia Cabrera Diaz

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

Oncologia Translacional

IP: Jaume Reventós Puigjaner
Collaborators: Soledad Gallego Melcón, Manuel López Cano, José Placer Santos, Josep Sánchez de Toledo Codina, Joan Morote Robles, Ma Teresa Quiles Pérez, Maria Asuncion Perez Benavente, Eva Colas Ortega, Miguel Segura Ginard, Berta Diaz Feijoo, Manuel Armengol Carrasco, Josep Castellví Vives, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Marina Rigau Resina, Maria Antonia Arbos Via, Jacques Planas Morin, Josep Roma Castanyer
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 57200
Reference: 2009 SGR 487
Duration: 01/01/2010 - 30/04/2014

La gestación como situación de estrés para el desarrollo de enfermedad cardiovascular: Evaluación de marcadores de riesgo hemodinámicos y bioquímicos para la enfemedad arterioesclerótica en madres y fetos con preclampsia y/o retraso de crecimiento.

IP: Elisa Llurba Olivé
Collaborators: Ferran Rosés i Noguer, Maria Queralt Ferrer Menduiña, Inés Zulema Calero Fernández, Silvia Cabrera Diaz, Josep Perapoch López
Funding agency: Instituto de Salud Carlos III
Funding: 61226
Reference: PI07/1095
Duration: 01/01/2008 - 30/06/2011

RTICC - Red Temática de Investigación cooperativa de cáncer

IP: Jaume Reventós Puigjaner
Collaborators: Joan Morote Robles, Ma Teresa Quiles Pérez, Francina Munell Casadesus, Eva Colas Ortega, Enric Trilla Herrera, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Tomàs Pinós Figueras, Rosanna Paciucci Barzanti, Marina Rigau Resina, Carles Xavier Raventós Busquets, Maria Antonia Arbos Via, Jacques Planas Morin, Josep Roma Castanyer
Funding agency: Instituto de Salud Carlos III
Funding: 350549.54
Reference: RD06/0020/0058
Duration: 02/01/2007 - 31/12/2013

Related news

From 6th to 7th March, more than 60 European researchers have shared the advances in translational research in endometrial cancer

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs.

Related professionals

Natalia Borruel Sainz

Natalia Borruel Sainz

Physiology and Pathophysiology of the Digestive Tract
Read more
Tudela Marti, Roger

Tudela Marti, Roger

Administrative Assistant
Patronage Unit
Communication Area
Read more
Herrera Rey, Lara

Herrera Rey, Lara

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more
Maria Angeles Jiménez Fuentes

Maria Angeles Jiménez Fuentes

Pneumology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.